Why are some people talking about buyout? It doesn't make logical nor business sense. I would rather see the impending milestone payments, approval of the drug, then mid-single digit royalties going straight to the bottom line (since there is no cost of goods sold expense for ILNS), further testing of the next generation therapeutic, and licensing of that drug. What do you think the value would be then versus a sell-out now? No way the company is going to sell now. It would be a lack of fudiciary responsibility.
Also, why are some people crying that the stock came down with potential that is there? Assuming the original premise is correct that the company's technology will lead to breakthrough theraputics than the current price action is a blip on the screen and affords an opportunity to load the boat. The drug is in its final phase of testing, Phase III, and has Pfizer and J&J involved. The scientist at PFE and JNJ certainly know a bit about chemistry and biology and they are in. Obviously I am long.
